Myeloma Immunotherapy
C. Ola Landgren/vjhemonc.com

C. Ola Landgren: Successful Myeloma Immunotherapy Preceptorship at Sylvester Myeloma Institute

C. Ola Landgren, Leader of Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared a post on LinkedIn:

“This past week, Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, University of Miami delivered another successful Preceptorship Program in Myeloma Immunotherapy!

It was our true pleasure to welcome almost 20 physicians and researchers from across the entire country of Brazil. During the 2-day Preceptorship Program, our visiting guests were attending world-class presentations by our faculty, as well as obserership in our clinics and research facilities. We all had a great time, learned a lot, shared ideas, and continued to expand our professional network!

These programs are great vehicles to move the field forward, and to stimulate new ideas and collaboration. We are already planning for next upcoming Preceptorship Program in Myeloma in the spring of 2026!”

C. Ola Landgren: Successful Myeloma Immunotherapy Preceptorship at Sylvester Myeloma Institute

More posts featuring C. Ola Landgren.